Quaeris
Tailored results will be delivered to you based on your preferences, past experiences, and specific role. QuaerisAI ensures that you have access to data that is almost in real-time for all your data needs. The platform boosts your data and document management tasks by leveraging AI technology.
To foster knowledge exchange and monitor progress, teams have the ability to share insights and create pinboards. Our sophisticated AI engine swiftly converts your inquiries into a format suitable for database processing within mere seconds. Just as life requires context, so does data; our intelligent AI engine analyzes your search terms, interests, roles, and historical data to rank results that encourage deeper exploration. Additionally, you can effortlessly apply filters to your search outcomes, allowing you to uncover specific details and delve into pertinent questions that arise. This seamless integration of AI not only enhances efficiency but also enriches the overall user experience.
Learn more
StackAI
StackAI is an enterprise AI automation platform built to help organizations create end-to-end internal tools and processes with AI agents. Unlike point solutions or one-off chatbots, StackAI provides a single platform where enterprises can design, deploy, and govern AI workflows in a secure, compliant, and fully controlled environment.
Using its visual workflow builder, teams can map entire processes — from data intake and enrichment to decision-making, reporting, and audit trails. Enterprise knowledge bases such as SharePoint, Confluence, Notion, Google Drive, and internal databases can be connected directly, with features for version control, citations, and permissioning to keep information reliable and protected.
AI agents can be deployed in multiple ways: as a chat assistant embedded in daily workflows, an advanced form for structured document-heavy tasks, or an API endpoint connected into existing tools. StackAI integrates natively with Slack, Teams, Salesforce, HubSpot, ServiceNow, Airtable, and more.
Security and compliance are embedded at every layer. The platform supports SSO (Okta, Azure AD, Google), role-based access control, audit logs, data residency, and PII masking. Enterprises can monitor usage, apply cost controls, and test workflows with guardrails and evaluations before production.
StackAI also offers flexible model routing, enabling teams to choose between OpenAI, Anthropic, Google, or local LLMs, with advanced settings to fine-tune parameters and ensure consistent, accurate outputs.
A growing template library speeds deployment with pre-built solutions for Contract Analysis, Support Desk Automation, RFP Response, Investment Memo Generation, and InfoSec Questionnaires.
By replacing fragmented processes with secure, AI-driven workflows, StackAI helps enterprises cut manual work, accelerate decision-making, and empower non-technical teams to build automation that scales across the organization.
Learn more
BIOiSIM
BIOiSIMTM is a revolutionary virtual drug development engine that offers significant advantages to the pharmaceutical industry by adeptly identifying drug compounds with strong potential for addressing specific diseases. Our range of translational solutions is designed to align with the unique requirements of your pre-clinical and clinical projects. At the heart of these offerings lies our trustworthy and validated BIOiSIMTM platform, which supports research on small molecules, large molecules, and viruses. Utilizing advanced models, this platform draws on data from thousands of compounds across seven different species, delivering a robustness that is rare in the industry. With a keen focus on human outcomes, it incorporates a translatability engine that efficiently translates insights between species. Importantly, the BIOiSIMTM platform is applicable before initiating preclinical animal trials, enabling earlier insights and significantly lowering costs linked to outsourced testing. This cutting-edge methodology not only improves efficiency but also hastens the overall drug development timeline, ultimately aiding the search for effective therapies. By streamlining the process, BIOiSIMTM has the potential to contribute to significant advancements in medicine.
Learn more
Genomenon
Pharmaceutical firms need a wealth of genomic information to successfully execute precision medicine strategies; however, they often utilize only a fraction—around 10%—of the total data at their disposal for decision-making. Genomenon offers an extensive database to counter this limitation. Their Prodigy™ Patient Landscapes deliver a cost-effective and efficient approach for conducting natural history research, which is crucial for developing treatments for rare conditions by expanding the understanding of both past and future health data. Employing a sophisticated AI-driven process, Genomenon meticulously analyzes each patient referenced in the medical literature much faster than traditional methods. It is essential to capture all pertinent insights by examining every genomic biomarker highlighted in scholarly articles. Each scientific assertion is backed by solid evidence sourced from medical literature, enabling researchers to identify all genetic factors and pinpoint variants classified as pathogenic according to ACMG clinical criteria, thus streamlining the creation of targeted therapies. By adopting this thorough strategy, pharmaceutical companies can significantly boost their research efficiency and, in turn, enhance patient outcomes. This innovative model not only fosters advancements in drug development but also contributes to a deeper understanding of genetic influences on health.
Learn more